| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Ya Cao | |
| Qian Tao | |||
| Li-Li Li | |||
| Zhao-Hui Wang | |||
| Xing-Sheng Shu | |||
| P2860 | cites work | Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? | Q22251049 |
| Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma | Q24323224 | ||
| Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? | Q27690752 | ||
| Worms gang up on bacteria | Q27860588 | ||
| Wnt/beta-catenin signaling in development and disease | Q27860784 | ||
| Genetic instabilities in human cancers | Q28131826 | ||
| Targeting RAS signalling pathways in cancer therapy | Q28201363 | ||
| Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation | Q28278843 | ||
| The epigenomics of cancer | Q28289975 | ||
| Cell cycle control and cancer | Q29617536 | ||
| OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. | Q33361612 | ||
| Differential gene methylation in undifferentiated nasopharyngeal carcinoma. | Q53381790 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Cell survival and a Gadd45-factor deficiency | Q59065679 | ||
| Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient | Q59344186 | ||
| Point mutation of the p53 gene is an infrequent event in untreated prostate cancer | Q71435022 | ||
| A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma | Q72065275 | ||
| Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells | Q33367808 | ||
| Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma | Q33594982 | ||
| TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma | Q33742715 | ||
| The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases | Q34099074 | ||
| Linking cell signaling and the epigenetic machinery | Q34143422 | ||
| A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma | Q34200303 | ||
| High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma | Q34515210 | ||
| The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. | Q34612189 | ||
| Genetic and epigenetic changes in nasopharyngeal carcinoma. | Q35008876 | ||
| MMPs, cadherins, and cell proliferation | Q35761991 | ||
| Focus on nasopharyngeal carcinoma | Q35773862 | ||
| The role of cell adhesion molecule in cancer progression and its application in cancer therapy. | Q35817994 | ||
| Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. | Q35927921 | ||
| Epigenetic changes in virus-associated human cancers. | Q36109306 | ||
| The cell cycle and cancer | Q36149494 | ||
| Current knowledge of the large RhoGAP family of proteins | Q36707513 | ||
| Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments | Q36810352 | ||
| The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells | Q37452295 | ||
| Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia | Q37476248 | ||
| Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers. | Q37562716 | ||
| Epigenetic deregulation of DNA repair and its potential for therapy | Q37578163 | ||
| Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. | Q39619011 | ||
| The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. | Q39714344 | ||
| The activation of p53 mediated by Epstein-Barr virus latent membrane protein 1 in SV40 large T-antigen transformed cells | Q40017833 | ||
| Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases | Q40117040 | ||
| Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling | Q40192981 | ||
| The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. | Q40252205 | ||
| The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. | Q40372729 | ||
| Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation | Q40413167 | ||
| Hypermethylation of the p16 gene in nasopharyngeal carcinoma | Q41191384 | ||
| Absence of p53 gene mutations in primary nasopharyngeal carcinomas | Q41604318 | ||
| Cell adhesion and signal transduction in cancer. Conference on cadherins, catenins and cancer | Q43119308 | ||
| Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma | Q43860639 | ||
| Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma. | Q44013848 | ||
| Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. | Q45069987 | ||
| Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. | Q46336393 | ||
| Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. | Q47794027 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | signal transduction | Q828130 |
| DNA methylation | Q874745 | ||
| CpG island | Q1138360 | ||
| nasopharyngeal neoplasm | Q58833953 | ||
| genetic epigenesis | Q64443099 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 231-239 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Chinese Journal of Cancer | Q15760211 |
| P1476 | title | Epigenetic disruption of cell signaling in nasopharyngeal carcinoma | |
| P478 | volume | 30 |
| Q89273955 | Association of E-cadherin methylation with risk of nasopharyngeal cancer: A meta-analysis |
| Q35987088 | Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay |
| Q34183409 | Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer |
| Q38667123 | Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases |
| Q37086051 | Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma |
| Q42668878 | Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest. |
| Q38249886 | Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells |
| Q37630359 | HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma |
| Q36544611 | Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma. |
| Q34359007 | Lowered risk of nasopharyngeal carcinoma and intake of plant vitamin, fresh fish, green tea and coffee: a case-control study in Taiwan |
| Q34708005 | MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma |
| Q35956645 | MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma |
| Q64250168 | NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription |
| Q35020438 | Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells |
| Q47155578 | Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development |
| Q33912908 | Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing |
| Q28073257 | Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer |
| Q58801315 | TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells |
| Q58741597 | TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma |
| Q38998765 | The Mechanics of Single Cell and Collective Migration of Tumor Cells |
| Q57826113 | The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest |
| Q41856646 | The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines |
| Q27016002 | Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma |
| Q92218667 | Tissue P16 is Associated with Smoking Status among Indonesian Nasopharyngeal Carcinoma Subjects |
| Q47383014 | UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells |
| Q59792009 | mA-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression |
Search more.